It lives in hotel showers, hospital water systems, and cooling towers. It causes fatal pneumonia. And cases have risen 900% in the United States since 2000. Here is what you need to know about Legionnaires' disease.
There is a bacteria that most people have never heard of. It does not spread from person to person. It does not appear on food. It leaves no visible trace. It grows silently inside the water systems of buildings we inhabit every day — hotels, hospitals, office towers, cruise ships — and spreads through the aerosols we breathe without ever noticing.
Its name is Legionella pneumophila, and the disease it causes — Legionnaires' disease — kills approximately 1 in 10 people it infects in the general population, and up to 4 in 10 among those who are immunocompromised. In the United States, reported cases rose by approximately 900% between 2000 and 2018. The trend has not reversed.[1]
This article covers the history of how Legionnaires' disease was discovered, how the bacteria spreads and why certain environments are high-risk, the clinical presentation and treatment, and what the 2024 global surge tells us about where the disease is heading.
In July 1976, the American Legion — a veterans' organization — held its annual convention at the Bellevue-Stratford Hotel in Philadelphia, Pennsylvania. It was a routine event by all appearances. Approximately 4,000 members attended.
Within days of the convention's end, attendees began falling ill with a severe and unusual pneumonia. By the time the outbreak was fully characterized, 221 people had developed illness and 34 had died. The case fatality rate — nearly 15% — was alarming by any measure.
The bacterium was named Legionella pneumophila — from the Latin pneumo (lung) and phila (loving) — and the disease it caused was named Legionnaires' disease in honor of the veterans who first suffered it.
The investigation also revealed something that had been hiding in plain sight: Legionella was not new. Retrospective analysis of stored samples identified what appeared to be Legionella outbreaks going back decades — including a 1965 outbreak at a psychiatric hospital in Washington D.C. that killed 16 people, and a 1968 outbreak in Pontiac, Michigan (now known as Pontiac fever, a milder form of legionellosis) that affected more than 100 people. The bacteria had existed long before it had a name.
Legionella pneumophila is a gram-negative, aerobic bacterium that exists naturally in freshwater environments worldwide — rivers, lakes, and soil. In nature, bacterial counts remain low and pose minimal risk to human health.
The danger emerges in what public health engineers call the built environment — the artificial water systems humans construct and maintain. Under the right conditions, Legionella can amplify from trace levels to infectious concentrations within weeks.
Transmission occurs exclusively through inhalation of aerosolized water droplets contaminated with Legionella. Aspiration of contaminated water is a less common but documented route, particularly in patients with swallowing difficulties.
There has been one reported case of possible person-to-person transmission in the scientific literature. It remains an exceptional rarity. Legionnaires' disease is not a communicable disease in the conventional sense. You cannot contract it from a sick person.
| Risk Factor | Relative Risk | Notes |
|---|---|---|
| Age ≥ 50 years | High | Rates increasing for all adults over 34 |
| Current or former smoker | High | Damages pulmonary clearance mechanisms |
| Immunosuppression | Very high | Fatality rate up to 40% in this group |
| Chronic lung disease (COPD, etc.) | High | Reduced mucociliary clearance |
| Chronic kidney or liver disease | Moderate–High | Impaired immune response |
| Diabetes mellitus | Moderate | Immune dysregulation |
| Recent travel (hotel stay, cruise) | Moderate | ~10% of U.S. cases are travel-associated |
| Hospital inpatient | Moderate–High | Healthcare-associated LD is a distinct category |
Notably, while the median age of patients with Legionnaires' disease in the U.S. is 62 years, outbreaks in occupational settings — such as the 2022 South Carolina manufacturing cluster documented in Emerging Infectious Diseases — have involved a younger demographic, with a median age of 40 years, demonstrating that intense environmental exposure can cause disease across age groups.[6]
Legionnaires' disease presents as severe pneumonia with systemic involvement. Symptoms typically begin 2 to 10 days after exposure, though the incubation period can extend up to 19 days in rare cases.
The combination of pneumonia with prominent gastrointestinal symptoms and neurological changes should raise clinical suspicion for Legionella, particularly in patients who have not responded to standard beta-lactam antibiotics (which are ineffective against intracellular bacteria).
Pontiac fever is a self-limiting, flu-like illness without pneumonia caused by Legionella species. It presents with fever, headache, and myalgia within 24–72 hours of exposure and resolves without antibiotic treatment within 2–5 days. Attack rates in exposed populations can be high — up to 95% — but no deaths have been attributed to Pontiac fever alone.[2]
Early and accurate diagnosis is critical to reducing mortality. The primary diagnostic tools are:
Legionnaires' disease responds to antibiotics that achieve adequate intracellular concentration. First-line options include:
Early initiation of appropriate antibiotic therapy is the strongest predictor of survival. Delays in diagnosis — often due to failure to consider Legionella in the differential — account for a significant proportion of preventable deaths.
The epidemiological trajectory of Legionnaires' disease in the United States is among the most striking in modern infectious disease surveillance. Reported cases rose from approximately 1,100 in 2000 to a peak of 9,933 in 2018 — an increase of roughly 900%.[1,7] Cases dropped during the first year of the COVID-19 pandemic (likely reflecting reduced occupancy of large buildings and reduced healthcare-seeking behavior), then rebounded in 2021 and have continued rising.
Crucially, the CDC and independent researchers estimate that the actual burden is significantly higher than reported figures suggest — with true incidence potentially 1.8 to 2.7 times higher than confirmed case counts, due to underdiagnosis and underreporting.[3,6]
The year 2024 brought a notable wave of Legionnaires' disease outbreaks across multiple continents, described in a November 2024 paper in The Lancet Microbe as a "global surge" requiring urgent awareness and preparedness.[3]
In Europe, the European Centre for Disease Prevention and Control (ECDC) reported a notification rate of 3.4 cases per 100,000 population in 2024, up from 3.2 in 2023. Males aged 65 and above were the most affected group. France, Germany, Italy, and Spain accounted for 71% of all notified EU/EEA cases.[4]
Legionnaires' disease is a reminder that some of the most dangerous infectious threats are not dramatic in their presentation — no rash, no person-to-person spread, no outbreak announcement on the news. They are quiet, environmental, and entirely preventable with the right infrastructure and awareness.
The 900% increase in U.S. cases since 2000, the 2024 global surge, and the persistent gap between reported and actual incidence all point to an infection that public health systems have not yet fully brought under control. The tools exist — water management plans, appropriate building maintenance, high clinical suspicion, and rapid diagnostic testing. What is needed is sustained commitment to using them.
If you work in healthcare, building management, or public health — this is a disease worth understanding deeply. And if you are a traveler or patient: knowing that Legionella hides in water systems, and knowing the symptoms of the pneumonia it causes, could one day make all the difference.